logo









Vividion therapeutics

Vividion therapeutics



Vividion Therapeutics is a biotechnology company that develops a groundbreaking drug discovery platform aimed at delivering transformative treatments for patients with serious illnesses through advanced chemical proteomics.
Sign up today to get real-time market insights on Vividion therapeutics and hundreds of other pre-IPO companies



Vividion therapeutics Overview

San Diego, CA, United States
2013
Healthcare/Wellness



Vividion therapeutics Live Market Data

$00000000
$00000000




Vividion therapeutics Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
Merger/Acquisition8/1/2021
Series C2/1/2021
Series B4/30/2019
Early Stage VC3/5/2018
Series A310/24/2017
Series A2
2/2/2017




Vividion therapeutics Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
ARCH Venture PartnersSeries B, Series A2, Series CSeries B (2019-04-30)
Altitude Life Science VenturesSeries BSeries B (2019-04-30)
Mubadala CapitalSeries B, Series CSeries B (2019-04-30)
Trinitas Capital (Beijing)Series BSeries B (2019-04-30)
BlackRock (NYS: BLK)Series CSeries C (2021-02-01)
SoftBank Investment AdvisersSeries CSeries C (2021-02-01)
T. Rowe Price Group (NAS: TROW)
Series C
Series C (2021-02-01)




Vividion therapeutics 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Vividion therapeutics data




Vividion therapeutics Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Vividion therapeutics data










DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.